• Mashup Score: 1

    Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.

    Tweet Tweets with this article
    • Immunotherapeutics have emerged as one of the most exciting new approaches to cancer treatment. Learn more in a special section on Immunotherapy: Pushing the Frontier of Cancer Medicine in the AACR #CancerProgressReport: https://t.co/NyYxgSoplA #CancerResearchSavesLives https://t.co/Co6n6zdCr5

  • Mashup Score: 0

    Unprecedented progress in medical research is driving remarkable improvements in cancer prevention, early detection, diagnosis, and treatment.

    Tweet Tweets with this article
    • October is #BreastCancerAwarenessMonth. In May, the USPSTF issued a recommendation for breast cancer screening, lowering the age of eligibility from 50 to 40. The AACR #CancerProgressReport notes that the revised recommendation could save 19% more lives: https://t.co/DajeSujDCy https://t.co/MuJ7r1mnwo

  • Mashup Score: 1
    CPR23 - Cancer in 2023 - 6 month(s) ago

    The U.S. cancer death rate has steadily declined since the 1990s, translating into more than 3.8 million cancer deaths avoided. However, progress has not been uniform against all cancer types.

    Tweet Tweets with this article
    • October is #BreastCancerAwarenessMonth. Treatment, detection, and prevention advances have driven a 43% reduction in the breast cancer death rate from 1989-2020, leading to an estimated 460,000 fewer deaths. Learn more in the AACR #CancerProgressReport: https://t.co/8aalfGe5r6 https://t.co/DTpJtwGqM8

  • Mashup Score: 3
    CPR23 - Cancer in 2023 - 6 month(s) ago

    The U.S. cancer death rate has steadily declined since the 1990s, translating into more than 3.8 million cancer deaths avoided. However, progress has not been uniform against all cancer types.

    Tweet Tweets with this article
    • Thanks to advances in treatment, the 5-year relative cancer survival rates for children (14 and under) and adolescents (15–19 years) have increased to 85% and 86%, respectively. Learn more in the AACR #CancerProgressReport: https://t.co/lD0IhepdtH #CancerResearchSavesLives https://t.co/xQsQwUExsM